€1.5m Price Tag Could Spell EU Success For BioMarin’s Hemophilia Gene Therapy
First Hemophilia A Gene Therapy Approval
The EU is vital for Roctavian's prospects, and the wider European and Middle East market two and half times larger than the US. • Source: Shutterstock 
